Horizon Pharma Public Limited Company was a big mover last session, as the company saw its shares rise nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, trading within a volatile range of $11.54 –$13.48 in the past one-month time frame, showed a sharp increase yesterday.

The move came after the company has settled another generic litigation for Pennsaid 2%.

The company has seen a mixed track record when it comes to estimate revisions of one increase and two decreases over the past one month, while the Zacks Consensus Estimate for the current quarter has moved lower over the same time period. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Horizon Pharma currently has a Zacks Rank #3 (Hold), while its Earnings ESP is negative.

A better-ranked stock in the Medical - Biomedical and Genetics industry is Alexion Pharmaceuticals, Inc. , which currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is HZNP going up? Or down? Predict to see what others think: Up or Down

4 Surprising Tech Stocks to Keep an Eye on

Tech stocks have been a major force behind the market’s record highs, but picking the best ones to buy can be tough. There’s a simple way to invest in the success of the entire sector. Zacks has just released a Special Report revealing one thing tech companies literally cannot function without. More importantly, it reveals 4 top stocks set to skyrocket on increasing demand for these devices. I encourage you to get the report now – before the next wave of innovations really takes off.

See Stocks Now>>